BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36604358)

  • 21. Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype.
    Fritzler MJ; Hudson M; Choi MY; Mahler M; Wang M; Bentow C; Milo J; Baron M;
    Autoimmun Rev; 2018 Mar; 17(3):267-275. PubMed ID: 29369808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.
    Lazzaroni MG; Marasco E; Campochiaro C; DeVries-Bouwstra J; Gonzalez-Perez MI; Rojas-Serrano J; Hachulla E; Zanatta E; Barsotti S; Furini F; Triantafyllias K; Abignano G; Truchetet ME; De Luca G; De Langhe E; Hesselstrand R; Ingegnoli F; Bertoldo E; Smith V; Bellando-Randone S; Poormoghim H; Colombo E; Ceribelli A; Furloni A; Zingarelli S; Cavazzana I; Franceschini F; Del Galdo F; Denton CP; Cavagna L; Distler O; Allanore Y; Airò P;
    Rheumatology (Oxford); 2021 Nov; 60(11):5028-5041. PubMed ID: 33580257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence and significance of anti-PM/Scl antibodies in systemic sclerosis.
    Wielosz E; Dryglewska M; Majdan M
    Ann Agric Environ Med; 2021 Mar; 28(1):189-192. PubMed ID: 33775087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antinuclear antibody pattern and autoantibody profiling of systemic sclerosis patients in a tertiary referral center in North India.
    Machhua S; Sharma SK; Kumar Y; Anand S; Handa S; Minz RW
    Pathol Int; 2022 May; 72(5):283-292. PubMed ID: 35319814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PM-Scl and Th/To in systemic sclerosis: a comparison of different autoantibody assays.
    Mecoli CA; Gutierrez-Alamillo L; Yang Q; Sampedro M; Woods A; Hummers LK; Wigley F; Shah AA; Casciola-Rosen L
    Clin Rheumatol; 2021 Jul; 40(7):2763-2769. PubMed ID: 33459953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
    Vázquez-Abad D; Grodzicky T; Senécal JL
    Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
    Shen CY; Li KJ; Lai PH; Yu CL; Hsieh SC
    Clin Rheumatol; 2018 Mar; 37(3):749-756. PubMed ID: 28940121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and autoantibody profile in systemic sclerosis: baseline characteristics from a West Malaysian cohort.
    Sujau I; Ng CT; Sthaneshwar P; Sockalingam S; Cheah TE; Yahya F; Jasmin R
    Int J Rheum Dis; 2015 May; 18(4):459-65. PubMed ID: 24618222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.
    Villalta D; Imbastaro T; Di Giovanni S; Lauriti C; Gabini M; Turi MC; Bizzaro N
    Autoimmun Rev; 2012 Dec; 12(2):114-20. PubMed ID: 22776784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic Sclerosis in Zimbabwe: Autoantibody Biomarkers, Clinical, and Laboratory Correlates.
    Sibanda EN; Dube Y; Chakawa M; Mduluza T; Mutapi F
    Front Immunol; 2021; 12():679531. PubMed ID: 34858387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study.
    Osthoff M; Jaeger VK; Heijnen IAFM; Trendelenburg M; Jordan S; Distler O; Walker UA
    Arthritis Res Ther; 2019 Mar; 21(1):76. PubMed ID: 30885245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between autoantibodies in systemic sclerosis and cancer in a national registry.
    Hoa S; Lazizi S; Baron M; Wang M; Fritzler MJ; Hudson M;
    Rheumatology (Oxford); 2022 Jul; 61(7):2905-2914. PubMed ID: 34599801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
    Mahler M; Maes L; Blockmans D; Westhovens R; Bossuyt X; Riemekasten G; Schneider S; Hiepe F; Swart A; Gürtler I; Egerer K; Fooke M; Fritzler MJ
    Arthritis Res Ther; 2010; 12(3):R99. PubMed ID: 20487535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.
    Jaeger VK; Wirz EG; Allanore Y; Rossbach P; Riemekasten G; Hachulla E; Distler O; Airò P; Carreira PE; Balbir Gurman A; Tikly M; Vettori S; Damjanov N; Müller-Ladner U; Distler JH; Li M; Walker UA;
    PLoS One; 2016; 11(10):e0163894. PubMed ID: 27706206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.
    Mendes C; Viana VST; Pasoto SG; Leon EP; Bonfa E; Sampaio-Barros PD
    Clin Rheumatol; 2020 Jan; 39(1):9-17. PubMed ID: 31065858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of CENP-B and Scl-70 autoantibodies in silicosis patients.
    Lee S; Hayashi H; Kumagai-Takei N; Matsuzaki H; Yoshitome K; Nishimura Y; Uragami K; Kusaka M; Yamamoto S; Ikeda M; Hatayama T; Fujimoto W; Otsuki T
    Exp Ther Med; 2017 Jun; 13(6):2616-2622. PubMed ID: 28587321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
    D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
    Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.